Head-to-head · Cost-Efficiency Index
Claya vs Kina
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Claya
Cost-first shoppers who want a same-price-any-dose semaglutide plan, for shoppers willing to consider a multi-month prepay to get the advertised rate.
Visit ClayaKina
Cost-first shoppers who want perimenopausal/menopausal women wanting GLP-1 weight management bundled with HRT and other menopause-specific care under one named clinical lead.
Visit KinaThe verdict
Claya and Kina tie on the Cost-Efficiency Index at 69/100, so neither wins outright on the numbers. For most shoppers we'd start with Claya (ranked #97, a hair above #103) — Cost-first shoppers who want a same-price-any-dose semaglutide plan, for shoppers willing to consider a multi-month prepay to get the advertised rate. But Kina is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Claya.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Claya | Kina |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 69/100 |
| Semaglutide / mo | $149/mo (all doses, compounded) | $169/mo (all doses, compounded) |
| Tirzepatide / mo | $199/mo (starting dose, compounded) | $249/mo (compounded) |
| Semaglutide / yr (modeled) | $1,788 | $2,028 |
| Tirzepatide / yr (modeled) | $2,388 | $2,988 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #97 | #103 |
Claya
69/100Where the value is
- Semaglutide is explicitly 'same price regardless of dosage' at $149/mo, removing dose-tier guesswork
- LegitScript Certified, BBB Accredited, and HIPAA Compliant badges all displayed together
- '$100 off your first month' promo code (100CLAYA) published openly with no intake required to see it
The tradeoffs
- The advertised $149/$199 rates are qualified elsewhere on the same page as available 'with select multi-month plans' — a shopper reading only the 'a month' headline could reasonably assume pure month-to-month billing when a prepay term may be required
- No state coverage list is published anywhere on the public site
Kina
69/100Where the value is
- Names an actual clinical lead (Dr. Shannon Arora, PharmD) tied to a real affiliated practice with an address
- LegitScript badge confirmed with verification link
- Consultation/physician-review fee is bundled into the price rather than charged separately
The tradeoffs
- $169 headline price is a first-month-only discount; true ongoing price is $199/mo
- Not a dedicated GLP-1 company -- weight/GLP-1 is one of six categories on a menopause-focused platform
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.